Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 17

    1.

    Infrequently studied congenital anomalies as clues to the diagnosis of maternal diabetes mellitus.

    Frías JL, Frías JP, Frías PA, Martínez-Frías ML.

    Am J Med Genet A. 2007 Dec 15;143A(24):2904-9.PMID: 18000913 [PubMed - indexed for MEDLINE]Related articles

    2.

    Incretins and their role in the management of diabetes.

    Frias JP, Edelman SV.

    Curr Opin Endocrinol Diabetes Obes. 2007 Aug;14(4):269-76. Review.PMID: 17940451 [PubMed - indexed for MEDLINE]Related articles

    3.

    Pramlintide reduced markers of oxidative stress in the postprandial period in patients with type 2 diabetes.

    Ceriello A, Lush CW, Darsow T, Piconi L, Corgnali M, Nanayakkara N, Frias JP, Maggs D.

    Diabetes Metab Res Rev. 2008 Feb;24(2):103-8.PMID: 17694505 [PubMed - indexed for MEDLINE]Related articles

    4.

    Pharmacokinetics of an oral drug (acetaminophen) administered at various times relative to subcutaneous injection of pramlintide in subjects with type 2 diabetes.

    Kellmeyer TA, Kesty NC, Wang Y, Frias JP, Fineman MS.

    J Clin Pharmacol. 2007 Jul;47(7):798-805. Epub 2007 Apr 26.PMID: 17463219 [PubMed - indexed for MEDLINE]Related articles

    5.

    Pramlintide as an adjunct to insulin in patients with type 2 diabetes in a clinical practice setting reduced A1C, postprandial glucose excursions, and weight.

    Karl D, Philis-Tsimikas A, Darsow T, Lorenzi G, Kellmeyer T, Lutz K, Wang Y, Frias JP.

    Diabetes Technol Ther. 2007 Apr;9(2):191-9.PMID: 17425446 [PubMed - indexed for MEDLINE]Related articles

    6.

    Pramlintide in the management of insulin-using patients with type 2 and type 1 diabetes.

    Pullman J, Darsow T, Frias JP.

    Vasc Health Risk Manag. 2006;2(3):203-12. Review.PMID: 17326327 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Pramlintide in the treatment of diabetes.

    Edelman SV, Darsow T, Frias JP.

    Int J Clin Pract. 2006 Dec;60(12):1647-53.PMID: 17109671 [PubMed - indexed for MEDLINE]Related articles

    8.

    Welcome to the first paediatric asthma guidelines directed by phenotype.

    Frías JP, Aragonés AM.

    Allergol Immunopathol (Madr). 2006 May-Jun;34(3):85-7. No abstract available. PMID: 16750117 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Pre-gestational maternal body mass index predicts an increased risk of congenital malformations in infants of mothers with gestational diabetes.

    Martínez-Frías ML, Frías JP, Bermejo E, Rodríguez-Pinilla E, Prieto L, Frías JL.

    Diabet Med. 2005 Jun;22(6):775-81.PMID: 15910631 [PubMed - indexed for MEDLINE]Related articles

    10.

    Optimizing insulin therapy in pregnant women with type 1 diabetes mellitus.

    Gottlieb PA, Frias JP, Peters KA, Chillara B, Garg SK.

    Treat Endocrinol. 2002;1(4):235-40. Review.PMID: 15799217 [PubMed - indexed for MEDLINE]Related articles

    11.

    Insulin lispro therapy in pregnancies complicated by type 1 diabetes: glycemic control and maternal and fetal outcomes.

    Garg SK, Frias JP, Anil S, Gottlieb PA, MacKenzie T, Jackson WE.

    Endocr Pract. 2003 May-Jun;9(3):187-93.PMID: 12917059 [PubMed - indexed for MEDLINE]Related articles

    12.

    Effect of obesity on susceptibility to fatty acid-induced peripheral tissue insulin resistance.

    Kruszynska YT, Olefsky JM, Frias JP.

    Metabolism. 2003 Feb;52(2):233-8.PMID: 12601639 [PubMed - indexed for MEDLINE]Related articles

    13.

    Fatty acid-induced insulin resistance: decreased muscle PI3K activation but unchanged Akt phosphorylation.

    Kruszynska YT, Worrall DS, Ofrecio J, Frias JP, Macaraeg G, Olefsky JM.

    J Clin Endocrinol Metab. 2002 Jan;87(1):226-34.PMID: 11788651 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Decreased susceptibility to fatty acid-induced peripheral tissue insulin resistance in women.

    Frias JP, Macaraeg GB, Ofrecio J, Yu JG, Olefsky JM, Kruszynska YT.

    Diabetes. 2001 Jun;50(6):1344-50.PMID: 11375335 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Metabolic effects of troglitazone therapy in type 2 diabetic, obese, and lean normal subjects.

    Frias JP, Yu JG, Kruszynska YT, Olefsky JM.

    Diabetes Care. 2000 Jan;23(1):64-9.PMID: 10857970 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Lack of effect of a physiological elevation of plasma non-esterified fatty acid levels on insulin secretion.

    Frias JP, Basabe L, Macaraeg G, Kruszynska YT.

    Diabetes Metab. 2000 Apr;26(2):133-9.PMID: 10804328 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Histoplasma panniculitis in dermatomyositis.

    Huston JW 3rd, McNabb PC 2nd, Frias JP.

    J Clin Rheumatol. 1997 Dec;3(6):353-7.PMID: 19078226 [PubMed - in process]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data

    Search details

    » See more...